Druggable driver gene alterations in redefined large cell carcinoma in Chinese patients: an observational study.

Yang, Jinhua; Li, Yuping; Ma, Benting; Xie, Huikang; Chen, Linsong; Gao, Xuejuan; He, Wenxin

Yang, Jinhua; Li, Yuping; Ma, Benting; Xie, Huikang; Chen, Linsong; Gao, Xuejuan; He, Wenxin.

Afiliação

Yang J; Department of Respiratory and Critical Care Medicine, Heping Hospital Affiliated to Changzhi Medical College, Changzhi, China.
Li Y; Department of Thoracic Surgery, Shanghai Pulmonary Hospital Affiliated to Tongji University, Shanghai, China.
Ma B; Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai, China.
Xie H; Department of Pathology, Shanghai Pulmonary Hospital Affiliated to Tongji University, Shanghai, China.
Chen L; Department of Thoracic Surgery, Shanghai Pulmonary Hospital Affiliated to Tongji University, Shanghai, China.
Gao X; BaylorOracle, Hangzhou, China.
He W; Department of Thoracic Surgery, Shanghai Pulmonary Hospital Affiliated to Tongji University, Shanghai, China.

Transl Cancer Res ; 9(12): 7562-7571, 2020 Dec.

Article em En | MEDLINE | ID: mdl-35117356

Palavras-chave

EGFR mutation; Gene alterations; KRAS mutation; large cell carcinoma (LCC)

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google